| | | All participants () | T2DM () | Non-DM () | |
| | Females, (%) | 125 (50) | 63 (45) | 62 (56.4) | 0.15 | | Age, yrs | | | | 0.54 | | Weight, kg | | | | 0.672 | | Height, cm | | | | 0.061 | | BMI, kg/m2 | | | | 0.571 | | Waist circumference, cm | | | | 0.073 | | Waist-hip ratio | | | | 0.382 | | Systolic BP, mmHg | | | | 0.174 | | Diastolic BP, mmHg | | | | 0.594 | | Pulse BP, mmHg | | | | 0.485 | | Heart rate, bpm | | | | <0.01 | | FPG, mmol/l | | | | <0.01 | | 2 h PPG, mmol/l | | | | | | Triglycerides, mmol/l | | | | 0.586 | | Total cholesterol, mmol/l | | | | <0.001 | | HDL cholesterol, mmol/l | | | | 0.025 | | LDL cholesterol, mmol/l | | | | <0.001 | | Serum creatinine mg/dl | | | | | | eGFR ml/min/1.73 m2 | 82.4 (73.1–104.9) | 70.8 (51.4–82.1) | 105.9 (76.2–118.7) | <0.001 | | Low eGFR, (%) | 43 (17.2) | 34 (24.3) | 9 (8.2) | 0.001 | | Angiopoietin 1, ng/ml | 38.2 (25.7–47.9) | 36.1 (24.7–42.1) | 41.1 (30–57.3) | 0.01 | | Angiopoietin 2, pg/ml | 740 (392–1107) | 838 (473–1241) | 597 (274–1005) | 0.018 | | VEGF-A, pg/ml | 63.2 (21.2–157.8) | 72.2 (28–201.8) | 48.4 (17.4–110.1) | 0.025 | | VPT, mV | | | | <0.001 | | Right ABI | | | | 0.135 | | Left ABI | | | | 0.132 | | Right leg PAD | 36 (14.4) | 29 (20.7) | 7 (6.4) | <0.001 | | Left leg PAD | 26 (10.4) | 21 (15) | 6 (5.5) | <0.001 | | Leg pains on exertion | 62 (24.8) | 43 (37.7) | 19 (17.3) | 0.004 |
|
|